AUROPHARMA Aurobindo Pharma Ltd Other Situations Announcement 2025 - Safety Incident Update Aurobindo Pharma Ltd provided an update regarding a safety incident at its subsidiary, Lyfius Pharma, on April 27, 2025, reporting an estimated loss of Rs. 40 million and awaiting pollution board approval to resume operations..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Aurobindo Pharma Ltd